Not much activity on HC despite RHP announcing a flurry of news/activity. Annual results look great. A long term hold for sure. Well done to long term holders. Future looks bright for RHP.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%